Cytomegalovirus (CMV), which causes a cold-like illness, can be spread in the same way as other viruses from person to person through body fluids such as blood, saliva and urine.
But the infection is present in up to 45 per cent of Alzheimer’s cases, US scientists have claimed.
Some people exposed to the bug may develop a chronic intestinal infection, allowing it to enter the bloodstream and travel to the brain.
Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder associated with a progressive decline in memory and mental abilities, which can significantly hinder people’s ability to complete daily tasks. Past studies found that patients diagnosed with AD, as well as some other neurodegenerative disorders, exhibit an abnormal accumulation of tau protein in their neurons.
Tau protein is a microtubule-associated protein (MAP) known to stabilize the internal structure of neurons, binding to microtubules. These are microscopic tubular structures that support the transport of nutrients, proteins and other vital molecules within individual neurons or other cells.
Recent findings suggest that tau proteins interact with extracellular vesicles (EVs), small membrane-bound particles secreted by cells that carry molecules and deliver them to other cells. While the research hints at a connection between these vesicles and tau proteins in AD, the link between the two is not yet fully understood.
Monitoring electrical potentials with high recording site density and micrometer spatial resolution in liquid is critical in biosensing. Organic electronic materials have driven remarkable advances in the field because of their unique material properties, yet limitations in spatial resolution and recording density remain. Here, we introduce organic electro-scattering antennas (OCEANs) for wireless, light-based probing of electrical signals with micrometer spatial resolution, potentially from thousands of sites. The technology relies on the unique dependence of poly(3,4-ethylenedioxythiophene):polystyrene sulfonate light scattering properties to its doping level. Electro-optic characteristics of individual antennas varying in diameters and operating voltages were systematically characterized in saline solution. Signal-to-noise ratios up to 48 were achieved in response to 100-mV stimuli, with 2.5-mV detection limits. OCEANs demonstrated millisecond time constants and exceptional long-term stability, enabling continuous recordings over 10 hours. By offering spatial resolution of 5 μm and a recording density of 4 × 106 cm−2, OCEANs unlock new readout capabilities, potentially accelerating fundamental and clinical research.
Sci. Adv. 10, eadr8380 (2024). DOI:10.1126/sciadv.adr8380
Select the format you want to export the citation of this publication.
Bioconvergence — Bridging Science And Nature To Shape Tomorrow — Dr. Nina Siragusa Ph.D. — Merck KGaA, Darmstadt, Germany
#NinaSiragusa #MerckGroup #Darmstadt.
Dr. Nina Siragusa, Ph.D., MBA, is the Strategy, Business, and Data & Digital Lead within the global R&D organization of Merck Healthcare KGaA, Darmstadt, Germany. In this role, she leads strategic projects, manages business operations, and drives digital transformation.
Previously, she served as Chief of Staff to Dr. Laura Matz, Chief Science and Technology Officer at Merck KGaA, Darmstadt, Germany. As part of the Science and Technology Office Leadership Team, she was responsible for fostering cross-sectoral collaboration, innovation, and digitalization across Merck’s three business sectors. She also spearheaded the company’s efforts in Bioconvergence, a multidisciplinary approach that synergizes biology, engineering, data, and digitalization. This initiative promises groundbreaking advancements in healthcare and the life sciences, heralding a new era of scientific collaboration for a healthier, more sustainable future.
Prior to that, Dr. Siragusa contributed to corporate innovation in several leadership roles:
One used AI to dream up a universe of potential CRISPR gene editors. Inspired by large language models—like those that gave birth to ChatGPT—the AI model in the study eventually designed a gene editing system as accurate as existing CRISPR-based tools when tested on cells. Another AI designed circle-shaped proteins that reliably turned stem cells into different blood vessel cell types. Other AI-generated proteins directed protein “junk” into the lysosome, a waste treatment blob filled with acid inside cells that keeps them neat and tidy.
Outside of medicine, AI designed mineral-forming proteins that, if integrated into aquatic microbes, could potentially soak up excess carbon and transform it into limestone. While still early, the technology could tackle climate change with a carbon sink that lasts millions of years.
It seems imagination is the only limit to AI-based protein design. But there are still a few cases that AI can’t yet fully handle. Nature has a comprehensive list, but these stand out.
How we classify cancer and spot it in its earliest stages could need an urgent rethink: researchers have found that even some healthy women carry cells with the key hallmarks of breast cancer.
These cells are known as aneuploid cells, and have an abnormal number of chromosomes. They’re common in invasive breast cancer, and it’s thought the chromosome imbalance enables cancer to spread and evade the body’s immune defenses.
Now it appears aneuploid cells might also be present even when there’s no cancer in sight. The researchers, from the University of Texas and the Baylor College of Medicine in Texas, found them in breast tissue samples from 49 healthy women.
Learn the key differences between cancer cells vs normal cells, including growth patterns, structure, and behavior, and how they impact cancer progression.
A study reveals artificial hearts can regenerate heart muscle cells, supporting the idea that resting the heart enables healing.
Whether cells in the human body survive or die under stress depends, among other things, on their mitochondria. Scientists at the Faculty of Medicine at the University of Freiburg have now shown that a sudden stop in energy production in mitochondria prevents normal cell death or so-called apoptosis and instead triggers an inflammatory response. The results of this research were published in the journal Immunity.
“We found that mitochondria provide a kind of decision-making aid: they regulate whether a cell undergoes clean, silent apoptosis or releases pro-inflammatory messenger substances,” explains Prof. Dr. Olaf Groß, head of the study, a scientist at the Institute of Neuropathology at the Medical Center—University of Freiburg and a member of the Cluster of Excellence CIBSS—Center for Integrative Biological Signaling Studies at the University of Freiburg.
“This finding helps us to better understand how the body maintains a balance between cell protection and defense mechanisms. This could open up new avenues for the treatment of inflammatory diseases.”
Researchers discovered that the mRNA modification m6A triggers rapid degradation, regulating protein production. This breakthrough could inform drug development to manage protein-related diseases.
Messenger ribonucleic acids (mRNA) are like the architects of our bodies. They carry precise blueprints for building proteins, which are read and assembled by their cellular partners, the ribosomes. Proteins are essential for our survival, as they regulate cell division, bolster the immune system, and make our cells resilient against external threats.
Just like in real-world construction, some cellular blueprints require extra instructions—such as when a protein needs to be produced rapidly or when corrections are needed for a flawed design. In our bodies, this role is fulfilled by RNA modifications. These small chemical changes function like detailed annotations, offering additional guidance to specific parts of the mRNA for optimal protein production.
